When Tillmann Sauerbruch introduced Didier Lebrec for the EASL Recognition Award 2013, he described a wonderful and truly European story. The Geoff-Dusheiko-Story is similar impressive, this time a global narrative! Born and trained in South Africa, two fellowships in the United States, Professor of Medicine at UCL in London, one of the world’s most requested “KOL” in the development of new therapies for viral hepatitis B and C, teaching fellows from various countries, scientific collaborations with different groups around the world and serving EASL for many years as an Education Councillor – Geoff Dusheiko significantly contributed to the development of our discipline.
No takes yet. Share an insight, caveat, or question.
Heiner Wedemeyer (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: